10.24
Sagimet Biosciences Inc Aktie (SGMT) Neueste Nachrichten
What analysts say about Sagimet Biosciences Inc. stockPhenomenal wealth increase - PrintWeekIndia
Why Sagimet Biosciences Inc. stock attracts strong analyst attention2x Return Forecast - Newser
What makes Sagimet Biosciences Inc. stock price move sharplyMarket Beating Strategy - Newser
Sagimet Biosciences Inc (SGMT) Stock: Navigating a Year of Volatility - investchronicle.com
Strategic Catalysts and Valuation Upside in Sagimet Biosciences (SGMT): A M&A-Driven Biotech Play - AInvest
Sagimet stock gains as Canaccord starts with Buy (SGMT:NASDAQ) - Seeking Alpha
This Sarepta Therapeutics Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Thursday - Benzinga
Sagimet Biosciences Inc. Stock Analysis and ForecastBreakthrough capital growth - Autocar Professional
Top Executives at Sagimet Biosciences Unload Significant Shares! - TipRanks
What drives Sagimet Biosciences Inc. stock priceMarket-crushing stock picks - Autocar Professional
Sagimet Biosciences Executives Sell Shares to Cover Tax Obligations - TradingView
TMO announces CFO retirement & internal successor effective 2026 | SGMT SEC FilingForm 4 - Stock Titan
Is Sagimet Biosciences Inc. a good long term investmentUnprecedented market success - jammulinksnews.com
How Sagimet Biosciences Inc. stock performs during market volatilityLow Volatility High Yield Stocks - Newser
what makes sagimet biosciences inc. stock price move sharplyShort Squeeze Radar - Newser
We Think Sagimet Biosciences (NASDAQ:SGMT) Can Afford To Drive Business Growth - Yahoo Finance
Is Sagimet Biosciences, Inc. technically bullish or bearish? - MarketsMojo
Eyes on Asia: AstraZeneca, NextCure, Sagimet Biosciences - BioXconomy
Wall Street Analysts Predict a 437.05% Upside in Sagimet Biosciences Inc. (SGMT): Here's What You Should Know - MSN
Sagimet Biosciences’ SWOT analysis: promising FASN inhibitor stock faces funding hurdles By Investing.com - Investing.com South Africa
Sagimet Biosciences’ SWOT analysis: promising FASN inhibitor stock faces funding hurdles - Investing.com
Analysts Offer Insights on Healthcare Companies: Pfizer (PFE) and Sagimet Biosciences, Inc. Class A (SGMT) - The Globe and Mail
Sagimet stock holds steady as JMP reiterates $31 price target By Investing.com - Investing.com Nigeria
Sagimet Biosciences Inc: Analyzing SGMT Stock Trends - investchronicle.com
Sagimet Biosciences Soars 10.6% on Upgraded Price Target - AInvest
Sagimet Biosciences Plunges 11.73% Amid Acne Treatment Updates - AInvest
Two Sigma Investments LP Trims Holdings in Sagimet Biosciences Inc. (NASDAQ:SGMT) - Defense World
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):